等级
pharmaceutical primary standard
API类
paroxetine
制造商/商品名称
USP
应用
pharmaceutical (small molecule)
格式
neat
SMILES字符串
O.Cl[H].Fc1ccc(cc1)[C@@H]2CCNC[C@H]2COc3ccc4OCOc4c3
InChI
1S/C19H20FNO3.ClH.H2O/c20-15-3-1-13(2-4-15)17-7-8-21-10-14(17)11-22-16-5-6-18-19(9-16)24-12-23-18;;/h1-6,9,14,17,21H,7-8,10-12H2;1H;1H2/t14-,17-;;/m0../s1
InChI key
QRQSGFFISBKLMZ-YHOFXEKLSA-N
基因信息
human ... SLC6A4(6532)
正在寻找类似产品? 访问 产品对比指南
一般描述
本品按现行药典规定交付。该产品的所有支持信息，包括SDS和任何产品信息宣传页均由药典发行机构制定并发布。如需更多信息和支持，请见现行药典的网站。
盐酸帕罗西汀是一种苯基哌啶衍生物，是选择性5-羟色胺再摄取抑制剂。其蛋白质结合能力高。该产品有两种形式，非吸湿性半水合物和吸湿性无水合物。这种药物还被认为具有治疗男性早泄的作用。
应用
盐酸帕罗西汀USP标准品的预期用途是USP规定的指定质量测试和检测。
生化/生理作用
盐酸帕罗西汀半水化合物是选择性 5-羟色胺再摄取抑制剂 (SSRI) 中作用最强、选择性最强的一种；抗抑郁药
分析说明
这些产品仅供测试和分析使用。它们不适用于人类或动物的给药，不可用于诊断、治疗或治愈任何疾病。
其他说明
可能适用相应的销售限制。
相关产品
产品编号
说明
价格
警示用语：
Warning
危险分类
Acute Tox. 4 Oral - Aquatic Acute 1 - Aquatic Chronic 1 - Eye Irrit. 2 - Skin Sens. 1 - STOT SE 3
靶器官
Respiratory system
WGK
WGK 3
闪点(°F)
Not applicable
闪点(°C)
Not applicable
E Di Girolamo et al.
Journal of the American College of Cardiology, 33(5), 1227-1230 (1999-04-08)
The purpose of the study was to determine whether the well tolerated serotonin reuptake inhibitor paroxetine hydrochloride could prevent vasovagal syncope in patients resistant to or intolerant of previous traditional therapies. Serotonergic mechanisms play a major role in the processes
C G McMahon et al.
International journal of impotence research, 11(5), 241-245 (1999-12-20)
To evaluate the efficacy of chronic and 'on demand' administration of paroxetine hydrochloride in the drug treatment of premature ejaculation (PE). Ninety-four normally potent men, aged 18-61 y (mean 39 y) with premature ejaculation were treated between January 1996 and
Perinatal outcome following third trimester exposure to paroxetine.
Costei, Adriana Moldovan, et al.
Archives of Pediatrics & Adolescent Medicine, 156.11, 1129-1132 (2002)
Solid-state forms of paroxetine hydrochloride.
Buxton, P. Christopher, Ian R. Lynch, and John M. Roe.
International Journal of Pharmaceutics, 42.1, 135-143 (1988)
Puja Panwar Hazari et al.
ChemMedChem, 9(2), 337-349 (2014-01-01)
A novel SiX-dipropargyl glycerol scaffold (X: H, F, or (18) F) was developed as a versatile prosthetic group that provides technical advantages for the preparation of dimeric radioligands based on silicon fluoride acceptor pre- or post-labeling with fluorine-18. Rapid conjugation
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门